CONSIDER BUYING $HGSI (HUMAN GENOME SCIENCES) ON DIPS ON ANTHRAX NEWS
$HGSI stock is dipping in the premarket on the news that FDA says its anthrax drug may not work. Our analysis shows that the anthrax drug is not material to the future of this company. The stock price has risen due to the success of the Lupus drug. Any large dips will be an over reaction and present a buying opportunity. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number